Mar 30, 2020
Biohaven Achieves Positive Results in Pivotal Trial of Oral NURTEC(TM), Dosed Every Other Day, for the Preventive Treatment of Migraine
Feb 14, 2020
WAT Medical's study finds that HeadaTerm TENS Therapy Provides a Fast Treatment for Acute Migraines in a Randomized Controlled Trial
Dec 23, 2019
FDA approves new treatment for adults with migraine
Oct 11, 2019
FDA approves new treatment for patients with migraine
Sep 26, 2019
Currax(TM) Pharmaceuticals LLC Announces First Acquisition: Acquires North American Rights to ONZETRA® Xsail®
Aug 08, 2019
Lilly Announces Positive Results for Emgality(TM) (galcanezumab) from the CONQUER Study in Patients who Failed Previous Migraine Preventive Treatments
Jan 17, 2019
Merck Manuals Addresses Common Misconceptions Around Migraines
Oct 19, 2018
New Migraine Surgery Textbook by Cleveland Surgeon and Procedure Pioneer
Oct 17, 2018
Express Scripts Offers New Value-Based Program for Migraine
Jul 11, 2018
Dr. Muhammad Mirza Helps Clients Escape Chronic Migraine Pain Through Botox
Jun 28, 2018
Amgen And Novartis Present New Data Demonstrating Long-Term Efficacy, Safety And Tolerability Of Aimovig(TM) (erenumab-aooe) In Patients With Chronic And Episodic Migraine
Jun 27, 2018
AHS 2018: Lilly's Emgality(TM) (galcanezumab-gnlm) Significantly Reduced Monthly Migraine Headache Days in Patients with Migraine Who Previously Failed BOTOX®* (onabotulinumtoxinA)
Jun 18, 2018
Migraine Abortion Phase 3 Trial (TEAM study) with Cefaly® ACUTE Medical Device is Progressing Quickly
Jun 11, 2018
Allergan's Oral CGRP Receptor Antagonist Atogepant Demonstrates Robust Efficacy and Safety in Episodic Migraine Prevention in a Phase 2b/3 Clinical Trial
May 31, 2018
Chronic Migraine Prevention Trial Shows Positive Results for Cefaly® PREVENT Medical Device
May 17, 2018
FDA approves novel preventive treatment for migraine
May 17, 2018
FDA Approves Aimovig(TM) (erenumab-aooe), A Novel Treatment Developed Specifically For Migraine Prevention
Apr 20, 2018
Allergan Showcases Leadership in Neurosciences with 25 Presentations at the American Academy of Neurology Annual Meeting in Los Angeles
Apr 17, 2018
When Others Fail, New Migraine Treatment May Work
Jan 29, 2018
gammaCore® Receives FDA Clearance for the Acute Treatment of Pain Associated with Migraine Headache in Adult Patients